Products billed under this code include Flucelvax Trivalent (2025/2026), Flucelvax Trivalent (2025/2026) (Preservative Free).
Payment limit per 0.5 ML, by effective quarter, 4Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Flucelvax Trivalent (2025/2026) | Seqirus Inc | 70461-0555-10 | 10 | $665.69 |
| Flucelvax Trivalent (2025/2026) (Preservative Free) | Seqirus Inc | 70461-0655-03 | 10 | $665.69 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $66.569 | +$17.074 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted September 17, 2026 |
| 3Q26 | $49.495 | $0.00 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted September 15, 2026 |
| 2Q26 | $49.495 | $0.00 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted September 15, 2026 |
| 1Q26 | $49.495 | $0.00 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted September 15, 2026 |
| 4Q25 | $49.495 | +$12.646 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted September 8, 2026 |
| 3Q25 | $36.849 | $0.00 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted March 10, 2026 |
| 2Q25 | $36.849 | $0.00 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted March 10, 2026 |
| 1Q25 | $36.849 | $0.00 | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted December 19, 2025 |
| 4Q24 | $36.849 | – | 0.5 ML | CCIIV3 VACCINE NO PRSC 0.5ML IM | v1, posted June 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
